✦ LIBER ✦

Hormonal Receptor Positive, HER2 Negative Metastatic Breast Cancer (MBC HR+HER2-): Pre and Post-Progression Costs Under the Public Health Care System (SUS) and Societal Perspectives in Brazil

✍ Scribed by Haas, L.C.; Fernandes, R.A.; Bines, J.; Caldas, A.; Valentim, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Costs of Hormonal Receptor Positive, Her

✍ Clark, O.A.C.; Paladini, L.; Engel, T.; Nishikawa, A.M.; Borges, L.; Caldas, A.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Costs of HER 2 Negative, Hormonal Recept

✍ Clark, O.A.C.; Paladini, L.; Engel, T.; Caldas, A.; Valentim, J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB